| Date Filed | Type | Description |
| 10/04/2023 |
4
| Lin Tai-An (Chief Scientific Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 24,000 shares
@ $0
Granted 75,000 options to buy
@ $22.8, valued at
$1.7M
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Cassidy James (Chief Medical Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 5,720 shares
@ $0 |
|
| 07/05/2023 |
4
| Smith L. Mary (Chief Development Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 5,720 shares
@ $0 |
|
| 05/25/2023 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 05/25/2023 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 05/25/2023 |
4
| Lewis-Hall Freda C (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 05/25/2023 |
4
| Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 05/25/2023 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 04/05/2023 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,375 shares
@ $25.25, valued at
$34.7k
|
|
| 03/20/2023 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 1,750,000 shares
@ $28.5, valued at
$49.9M
|
|
| 03/16/2023 |
4
| Hambleton Julie (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 1,106 shares
@ $31.5021, valued at
$34.8k
|
|
| 01/27/2023 |
4
| Pichl Daniel (Chief People Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 858 shares
@ $31, valued at
$26.6k
|
|
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,464 shares
@ $56.9, valued at
$83.3k
Granted 100,000 options to buy
@ $26.98, valued at
$2.7M
|
|
| 10/11/2022 |
3
| Cassidy James (Chief Medical Officer) has filed a Form 3 on SpringWorks Therapeutics, Inc. |
| 09/14/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 123,897 shares
@ $31.96, valued at
$4M
Sold 30,000 shares
@ $31.98, valued at
$959.4k
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|